The inaugural Vicky Amidon Innovation in Lung Cancer Research Award is named in the memory of Vicky Amidon, a beloved wife, mother and friend to many. At the age of 44, Vicky was diagnosed with lung cancer and faced a difficult two-and-a-half year battle with the disease. Vicky’s memory continues to impact many lives and is furthered through her family’s advocacy and support for the advancement of lung cancer research and awareness. The award recognizes and supports researchers who are developing innovative lung cancer projects that will improve the lives of those at risk of or living with lung cancer.
Andrew Bishop, PhD, Wake Forest School of Medicine, part of Wake Forest Baptist Health
The Lung Cancer Initiative of North Carolina, the state’s leading non-profit organization supporting lung cancer research and education, is pleased to announce Andrew Bishop, PhD, Wake Forest School of Medicine, part of Wake Forest Baptist Health, as the first recipient of the Vicky Amidon Innovation in Lung Cancer Research Award in the amount of $25,000.
Dr. Bishop’s project will evaluate the potential to develop a lung cancer screening breath test to be used by clinicians for non-invasive lung cancer screening.
Lung cancer is a complex disease that currently requires invasive diagnostic tests. “Detecting lung cancer signatures in exhaled breath would greatly impact a clinician’s ability to detect cancer earlier and with minimally invasive tests, thereby impacting patient treatment and outcomes,” Dr. Bishop said.
Dr. Travis Dotson, MD
Dr. Christina Bellinger, MD
Dr. Jim Wudel, MD
Dr. Kimberly Reeves, PhD
Dr. Tony Reeves, PhD